Healthcare.

The future of healthcare is prevention, not repair. I predict AI diagnostics, personalized medicine, genomics (reading your DNA to tailor treatment), wearables, and predictive systems will improve outcomes while cutting cost. The model flips. Instead of waiting for you to get sick, the system monitors, predicts, and intervenes early. Big Tech is already inside: Apple and Samsung on your wrist, Google and Microsoft in the hospital data. I have warned against fast food and processed food on stage for 25 years, because prevention starts with what you eat, not with a pill. Medicine stops being a repair shop and becomes a guardian.

Healthcare is a $10 trillion industry. Digital health alone passes $1 trillion by 2030, and I say Apple takes $150 billion of it. By 2030 health stands next to iPhone and Services as a pillar of Apple's business model. Not an accessory. A pillar.

Big pharma is McDonald's serving hamburgers without owning a cow: it owns patents, never healing. A mushroom that grows for free is a threat until it becomes a patented molecule at $5,000 to $10,000 per treatment. The same industry branded weed a gateway drug while it flooded the world with opioids. There is exactly 1 gateway drug, and it is big pharma.

Oregon and Colorado roll out therapeutic psilocybin. The FDA panel rejected Lykos' MDMA treatment in 2024. Usona pushes psilocybin through the final trial phase with breakthrough status. Ibogaine is studied for addiction, PTSD and brain injuries. The money is racing ahead of the guardrails.

No. AI catches cancer earlier and designs drugs faster. It does not cure it. Timing is everything in cancer, and timing is what AI moves. Follow the money. Cancer drugs are pharma's biggest market: $291 billion in 2025, about $470 billion by 2030. A cure sells once. A treatment sells for years. That is why the money flows to detecting and treating, not curing. The patient pool is exploding. 21 million new cases in 2024, a record. Cancer under 50 up 79% since 1990, steeper since the pandemic. Turbo cancer is in the news everywhere, and a South Korean study of 8.4 million people found higher cancer risk after COVID vaccination. The registries run 2 to 3 years behind. When the 2023 to 2025 data land, I forecast the fastest rise in cancer cases in modern history. Where AI wins: detection. The first randomized trial, 105,934 women, The Lancet 2026: AI plus 1 radiologist found 29% more cancers than 2 radiologists. 1,451 AI devices cleared by the FDA. No AI-designed drug approved anywhere yet. My forecast: by 2030 AI reads every scan and catches most cancers 1 stage earlier. First AI cancer drug at scale, early 2030s. No cure by 2030. Cancer is 200 diseases. My own cancer was pre-AI. When I was 32 years old, doctors diagnosed me with non-Hodgkin lymphoma, stage 4, and gave me 6 to 12 months to live. I am super grateful I survived, but it cost me part of my immune system. I am not a doctor. Talk to yours, and get screened.

Psychedelics either transform mental health for millions, or become another patented luxury sold back to the desperate at $5,000 to $10,000 a treatment. I do not trust the referees, on the record since the COVID years, when cheap medicines got buried and the science got bought. I side with the healing, not the patent.

Yes, psilocybin and MDMA delivered strong results in landmark trials. The science is no longer the question. A single dose of psilocybin lifted well-being for at least a year in the landmark studies. MDMA-assisted therapy took the majority of PTSD patients in final-phase trials below the diagnosis line. The US FDA still rejected MDMA therapy in August 2024 and asked for 1 more final-phase trial. Cannabis already produced an FDA-approved epilepsy medicine. Nature keeps passing its own tests.

$10 billion by 2027 to 2028 on my call, as MDMA, psilocybin and lab-made variants move from underground ceremonies to corporate patents. What started as a movement to heal PTSD, depression and addiction has become a boardroom land grab.

No. Ragebait merchants selling hate are the same disease in new clothes. Journalism has 1 job, investigate power, and the outsiders who do that now own trust. By 2030 the scarcest asset in media is trust, and the mainstream already spent it. Verify the independent too.

Because the cheapest calories hit the poorest hardest. My fight is solving poverty, so people can afford real food, and calling the greasy empire what it is, on stage for 25 years. The pill treats the symptom, the bag is the disease. I predict the $1.2 trillion. I fight the 3 billion.

For obesity and diabetes, yes, with limits. The SELECT trial found 20% fewer heart attacks, strokes and cardiac deaths combined, in people who already had heart disease. No trial runs past 4 years, weight returns faster after stopping, and Cochrane warns the makers funded most trials. UK regulators logged 1,176 pancreatitis reports and 18 deaths on Mounjaro alone and issued a class-wide fatal-pancreatitis warning in January 2026.

My name for Apple's hidden health empire. Apple owns no hospitals, yet it put a hospital-grade sensor network inside a watch and earbuds and books the money where no analyst can see it. No reported number means no analyst model, and no model means nobody prices it.

$1.2 to $1.5 trillion in tax income lost by the West by 2030 on the wealth that departed, money that paid for pensions, hospitals and schools, now taxed in Dubai at 9% instead of Paris at 45%. Behind it sits the gravity shift: the BRICS economies produce $31.9 trillion a year and build their own payment rails outside the Western system.

3 walls closing on those who stay by 2030. Wall 1, your identity: signed law forces all 27 EU states to offer a government digital ID wallet by 24 December 2026, your passport, license, diplomas and medical records in 1 state app. Wall 2, your money: the digital euro pilots in 2027, rolls out in 2029. Wall 3, your movements: the Entry/Exit System, live since October 2025, logs every border crossing by face and fingerprint.

Very. Of 469 BPC-157 samples tested in 2026, 68% failed on quality, doses off by up to 80%. Why: a peptide is cheap to copy and the FDA's 2023 crackdown pushed users to "research use only" vendors. Crypto-paid peptide sales pass $100 million a year. 2 women in Las Vegas ended in hospital after unknown peptides at an anti-aging clinic. If it did not come from a pharmacy with your name on it, do not inject it.

The $2 trillion in social-enterprise revenue is earned in education, agriculture and food, and healthcare first, then clean energy, financial inclusion, creative industries and care. Of the $1.6 trillion in impact capital, climate rose from 6% in 2018 to 48% in 2023, and 94% of impact investors say returns met or beat expectations.

Yes. It is the only thing that ever has. Hunger, energy, clean water, disease: every one of them shrank because somebody invented something, not because a committee met. And now the tools are exponential. AI, robotics, biotech, and clean energy let us solve global challenges at a scale and pace no government ever reached. I am not a doomer and not a blind optimist. I am an operator, and I have watched invention beat problems the experts called impossible. Boyan Slat is the proof: he started at 18 and his Ocean Cleanup has already pulled 50 million kilos of plastic out of the sea. The threats are real. The fix is always the same: build.

Partly. But not without a fight. Agriculture is no longer only about soil, tractors and livestock. Food is increasingly being engineered in labs and bioreactors. Gene editing can create crops that resist disease, tolerate drought or mature faster. Precision fermentation uses programmed microorganisms to make proteins without the animal. Cultivated meat grows animal cells directly. 3D food printing can shape plant-based or cultivated ingredients into steaks, fish and other foods. The hype ran ahead of reality. Cultivated meat was once forecast to become a multibillion-dollar market by 2030, but scaling bioreactors, cutting costs, winning consumer trust and clearing regulation have proved harder than promised. GMOs need nuance. Major scientific reviews have not found currently commercialized genetically engineered foods to be inherently more dangerous to eat than conventional equivalents. That does not mean every future gene-edited crop, animal or production system is automatically safe. New products still need testing, transparency and scrutiny. Then there is Apeel. Its plant-derived coating is designed to slow moisture loss and extend produce shelf life. The Gates Foundation funded early Apeel research, but Bill Gates does not own or run Apeel. Apeel says its coatings are not GMO-derived. My concern is bigger than one tomato or one company: who controls the seeds, patents, food technology, farm software and agricultural data? My view is clear: Bill Gates is a danger to society when concentrated private influence reaches too deeply into food, health, technology and public policy. That is my opinion, not a scientific finding. My forecast: by 2030 engineered food grows fast, but it does not replace traditional agriculture. The real battle will be over safety, labeling, ownership, transparency and consumer choice. Innovation is welcome. Control without accountability is not.

Human enhancement uses technology to upgrade body and mind beyond what nature gave you. I predict wearables, implants, brain-computer interfaces (chips that connect your brain to a computer, the kind Elon Musk's Neuralink already puts in paralyzed patients), and biotech will boost physical ability, cognition, and health, while raising deep ethical questions. The line between treatment and enhancement blurs fast: a chip that lets a paralyzed man type is medicine, the same chip in a healthy stockbroker is an upgrade. The debate moves from whether we can to whether we should, and who gets access. That conversation cannot wait for the technology to arrive.

No. Wellness is full of vibes pretending to be evidence. NAD+ drips, IV ozone, hyperbaric chambers, mushroom powder and the dopamine detox are not healthcare. The market splits in 2 by 2030: proven interventions become trusted infrastructure, pseudoscience becomes expensive content. Wellness is about a better Tuesday, not a miracle.

Brain-computer interfaces become one of the most transformative technologies of the century. A brain-computer interface is a chip or headset that lets your brain talk to a computer directly, and Elon Musk's Neuralink already has paralyzed patients moving cursors by thought. I predict direct communication between humans and machines opens new frontiers in healthcare, education, communication, and productivity. First they restore lost function for patients. Then they extend capability for everyone. The interface between mind and machine becomes the ultimate platform, and the ultimate ethical test. Technology can empower or control humanity. I picked a side.

Not at mass-market scale by 2030. Today, light-field displays (Looking Glass, the US maker of glasses-free 3D screens) already show convincing 3D images to several viewers at once. Digital holography is real business in microscopy, medical imaging, industrial inspection, telepresence and displays. Healthcare is its biggest customer, not the concert stage. But Hollywood set a much harder bar: a life-size person floating in open air, visible from every angle, no glasses, no screen, no projector trick. That stays hard because the system must control huge amounts of light and data in 3D space while becoming bright, safe, affordable and mass-producible. An avatar on a stage is not that. A digital twin on a screen is not that either. The numbers agree. Grand View Research puts digital holography at $5.7 billion in 2026 and $23.5 billion by 2033, growing 22.3% a year: about $12.8 billion by 2030. Other houses land between $10.1 billion and $18.7 billion for 2030. A niche, next to the $270.6 billion avatar market and the $1.07 trillion XR market. My forecast: by 2030 spectacular "holographic" experiences are common in entertainment, retail and telepresence, but most run on light-field displays, transparent screens, AR or projection. Princess Leia (the 1977 Star Wars hologram) floating in your room with no glasses? Still a lab demo in 2030. The future looks holographic long before it becomes holography.

Humanoid robots will take over parts of the workplace, not the whole workplace. I predict humanoids become common across logistics, manufacturing, hospitality, healthcare, and services, attacking labor shortages while lifting productivity, and I forecast $12 trillion a year in robot work by 2050. The form factor is the trick: a robot shaped like a human slots into spaces built for humans without a facility redesign. That is why Tesla's Optimus, Figure, Agility, and China's Unitree race now, and why BMW and Amazon already test them on the floor. My 15-year-old rule holds: by 2030 robots and AI take roughly 30% of repetitive work, parts of jobs, not whole jobs. Let the machines take the heavy, dirty, and dangerous. Humans move up to the meaningful, the social, and the creative.

The future of longevity is more healthy years, not just more years. I predict biotech, AI, diagnostics, and personalized medicine extend healthy human lifespan significantly, and the focus shifts from treating disease to preventing, delaying, and potentially reversing aging itself. People over 60 spend $19 trillion today, $40 trillion by 2036 on my call. Follow the money: Jeff Bezos backs Altos Labs, Sam Altman backs Retro Biosciences, Bryan Johnson spends $2 million a year on his own body, and Novo Nordisk and Eli Lilly now sell their weight-loss drugs as the first longevity pills. Watch who sells you the subscription: big pharma never found a cure in its life, because cures kill subscriptions. I frame longevity as several exponential technologies hitting medicine at once. The question is no longer if, but how soon, and for whom. My warning stays: no pill beats real food and a body you actually use.

Post-human evolution is the merging of biology and technology in future generations. I predict brain-computer interfaces, biotech, AI, and advanced medicine will fundamentally change what it means to be human over coming centuries. Evolution stops being purely biological and becomes partly engineered. I call this the most consequential and least discussed long-term trend on the table. The species itself becomes a design project.

Drones are becoming the eyes of the farm. They already map fields, monitor crop health, detect pests and disease, inspect irrigation, measure plant stress and spray crops. With thermal and multispectral cameras, they can show which parts of a field need water, nutrients or treatment before the problem is obvious from the ground. The next step is AI. Instead of producing images for a farmer to inspect, drones feed data into farm software that decides where to spray, water, fertilize or investigate. Adoption is still early. FAO research shows drone use is growing, but still far from universal. That matters because the opportunity is not replacing every tractor. It is giving farmers a faster, cheaper view of every hectare. My forecast: by 2030 drones become standard equipment on advanced farms, especially for crop monitoring, spraying, irrigation and high-value agriculture. The tractor sees the row. The drone sees the whole farm.

All of them, because the forces are the same. AI, robotics, energy, space, biotech, and media hit retail, finance, healthcare, mobility, sports, and marketing at the same time. Industry experts sit in their lane and miss the collision. I connect the lanes: 2,500+ keynotes across every sector, from Amazon, L'Oréal, and Nike to governments and cities. The question is never what happens to my industry. It is what happens to every industry at once, and who moves first.

By 2100, humanity operates inside a radically different technological order. I predict AI, human augmentation, advanced medicine, autonomous infrastructure, and space expansion fundamentally reshape how people live, work, and connect. I use 2100 as a thinking tool, a horizon far enough to free the imagination and close enough to inform the decisions you make today. The future gets built backward from there.

Human cloning keeps advancing while raising profound ethical, legal, and societal questions. Cloning means creating a genetic copy of a living thing, and it has been real since Dolly the sheep in 1996. Today China clones pigs and monkeys at scale, and US companies clone pets for $50,000. I predict therapeutic cloning (growing your own cells or organs for transplant, no copy of you) grows in medical importance, while cloning a whole human stays one of the most controversial frontiers in science, banned in most of the world. The pattern is the one I warn about everywhere. The science sprints ahead of the ethics. Closing that gap is the real work, and it is overdue.

For lower taxes, fast residency, safety, and governments that protect builders. Count the benefits like a migrating herd counts water. Dubai: 9% business tax, 0% on your income, a 10-year golden visa. Panama taxes only what you earn inside the country. Paraguay makes residency cheap and fast. Add safe streets, enforced borders, affordable world-class healthcare, and governments that protect builders instead of punishing them. The West rolls out exit taxes, the East rolls out red carpets.

Birth registration is the first link in a chain. The UN wants every human on paper by 2030. Then on a screen. Agenda 2030, Target 16.9: legal identity for all, including birth registration, by 2030. The UN’s definition covers your identity from birth certificate to death certificate. The World Bank supports the effort. It helped over 60 countries provide digital IDs, benefiting 550 million people. Next link: money. In the Philippines, free bank accounts at ID registration centers created 8 million new accounts. In 2018, the World Economic Forum and partners launched a biometric digital travel ID prototype, with Canada and the Netherlands developing a pilot. Every EU state must offer a digital ID wallet by December 24, 2026. The digital euro pilot is planned for 2027. Birth certificate. Digital ID. Bank account. Digital payments. No secret bond needed. Every initiative is public and documented. For 800 million people without official ID, identification can open doors to banking and healthcare. In Vietnam, banks moved to delete 86 million unverified or dormant accounts under biometric identity rules. Technology can empower or control humanity. Being counted is not the danger. Who controls the count is. I fear people, not technology. Igor Beuker

Yes, we still work in 2050, but machines do most of the work we hate. Fewer hours, different jobs, more machine leverage. The prophets say otherwise. Elon Musk says AI and robots make work optional within 10 to 20 years and a universal basic income pays the bills, he calls it universal high income. Sam Altman funded the test: 1,000 Americans got $1,000 a month for 3 years, no strings. Result: they worked 1.3 hours a week less and were more likely to be job-hunting. Employment dipped 2 points. People kept working. That is the only one of the 2 with data, and the data says people keep working. Brilliant builders, not prophets. Each of them sells the robot, the software or the chip that needs you to believe it. The tape today says transformation, not extinction. Amazon passed 1 million robots in 2025, 5 times its 2019 fleet, while its headcount peaked in 2021 and has shrunk since to 1.56 million. McKinsey sold the automation decks, then cuts 10% of its own support staff as AI takes the work. Technology can empower humanity or control it. The only thing that controls technology is us, the people. I choose tech for good. I predicted this 15 years ago: if we imagine the future, robots and AI take over our repetitive, routine, dangerous, dirty and mind-killing jobs. By 2030 that is 30% of routine work, parts of jobs, not whole jobs. What we humans do is hospitality, service and mindful jobs: care, leadership, creativity, relationships, teaching, craftsmanship, judgment, wellbeing. That prediction holds for 2050. A basic income may become part of the safety net. It will not be the reason you stop working. I have no robot to sell and no share price to defend. The future is not humans versus robots. It is deciding which work stays human.

Quiet cutting is a layoff without the courage: a company moves you to a smaller, lower-profile role instead of firing you, and hopes you resign. No severance, no headline. In the UK and some European countries a reassignment that breaks your contract can count as constructive dismissal and end in court. In the US it ends on Glassdoor. The tape, 2 US surveys from 2023: 24% of business owners admitted they quietly cut (Zetwerk), and 59% of workers moved to a worse role that year later quit (ZipRecruiter). The cousin tactic: 1 in 4 executives admits hoping a return-to-office rule would push people to resign (BambooHR). Ghosting is the same disease: 66% of job seekers got silence after an interview, 18% after a verbal offer. The bill: global engagement fell to 20% in 2025, the lowest since 2020. Gallup prices that at $10 trillion a year in lost productivity. My opinion: quiet cutting is cowardice sold as cost control. The best people read the silence first and leave first. My prediction: by 2030 quiet cutting is the fastest way to lose the talent war. The talent walks to founders who say it to your face. A leader fires with respect. A coward reassigns.

Digital identities are secure, verifiable proof of who you are online, for people, organizations, and assets: a passport for the internet. I predict they become essential infrastructure as commerce, education, healthcare, and government move online, and the rollout is already dated: every EU state must offer the digital ID wallet in 2026, your papers, health data, and permits in 1 app. In an era of deepfakes and synthetic accounts, proving you are who you claim to be is no longer a feature. It is the foundation the entire digital economy stands on. My warning stays: digital ID plus digital euro is a control grid if the wrong people write the rules. Whoever owns the standard owns the flow. The technology can empower or control society. I picked a side. Fear sells. Imagination builds. Imagine a bright future, then create it.

$1 trillion by 2035 on my call, with McKinsey's high end at $2.7 trillion. Quantum is not a faster computer. It is a lockpick in a lab coat: the machine that simulates a cancer cure picks the lock on every bank, every wallet, every secret you ever encrypted.

Tech for Good means using technology to empower people, not to control them. Technology can empower or control humanity. Tech for good or tech for greed. Choose. I fear people, not technology. The same AI can cure cancer or sell your kids a feed of nonsense at 2 a.m. Big Tech built the second one first. Meta's innovation graveyard is full of "connecting the world" slogans. I chose: 100% of my speaking fees fund social innovation, 24 social startups, no sponsors, no ads. Not a hashtag. A wire transfer.

ASI is intelligence that surpasses the best human minds in nearly every field. I treat it as a civilization-level event, not a product launch. It could transform science, medicine, economics, and governance while raising control questions humanity has never faced. ASI is the line where the tool out-thinks the toolmaker. Cross it wide awake. Do not confuse ASI with the White House label. Since 29 September 2026 the US government and the Big Tech CEOs call plain AI "Super Intelligence" (SI). A rebrand is not a breakthrough. My forecast: ASI between 2030 and 2040. And my doctrine does not change at the line: the only thing that controls technology is us, the people. I fear people, not technology.

Since 2025, influencers need verified professional credentials to talk about medicine, law, finance, or education. No degree, no broadcast. Half of KOL content is non-experts making claims. That half just became illegal. The MCN agencies that manufacture these stars build on land the party can reclaim with 1 memo.

Because a peptide is cheap to copy. Fake Ozempic pens filled with insulin sent buyers in Austria and the UK to hospital. Chinese labs ship raw semaglutide powder online as "research peptides", and wellness clinics stack it with unapproved healing peptides like BPC-157. If it did not come from a pharmacy with your name on the label, do not inject it.

Philips, the whole company, medical imaging, hospital monitors, personal health, sells $19 billion a year growing 1 to 3%. Apple's health side project sells $15 billion. The side project is about to eat the specialist: the gadgets are the Trojan horse, the empire is services, subscriptions and the health data layer.

No. The pill treats the symptom. Fast food and processed food are the disease, and I have said so on stage for 25 years. Stop the drug and the weight comes back, while the shelf that built the appetite is still there. We built a $100 billion industry to sell the antidote to the poison, and both sides bill you monthly.

Gene editing gives us real power to prevent disease, and designer babies are the dark side of the same tool. CRISPR, the technology that lets scientists cut and rewrite DNA like a text editor, already delivered the first approved cure: Casgevy for sickle cell disease, approved in 2023. I predict real medical benefit alongside serious ethical danger around enhancement and selection. The same tool that eliminates an inherited disease can also write inequality into DNA, and China already jailed the scientist who edited the first babies in 2018. I am firm. The governance conversation cannot lag the science, because once this genie escapes, it does not go back.

Not yet. The entire published human record on BPC-157, the most injected healing peptide, is 1 small study of 12 patients, with no human safety data. Rodents heal. Humans have barely been tested. Non-approved peptides with a large human trial: 0. In July 2026 an FDA panel shaped by RFK Jr. recommended 6 of 7 peptides for prescription compounding anyway, 8 votes to 6, against the FDA's own scientists: a recommendation, not an approval. My call: BPC-157 gets its first 1,000-person trial by 2030, or the market learns nobody will fund one.

No. Wall Street's own 14-analyst spread on Apple healthcare runs from $15 billion to $313 billion by 2030. My $150 billion is the middle of their road, driven faster. When the models spread that wide, the wave is bigger than the models.

Artificial wombs are machines that grow a baby outside the body, and they could reshape healthcare, fertility treatment, and neonatal care. Today the technology means a fluid-filled bag that keeps extremely premature babies alive, tested on lambs at the Children's Hospital of Philadelphia and now moving toward human trials. I predict that as it matures, it challenges deep assumptions about reproduction, family, and human development. It begins as a medical breakthrough for premature infants. Its longer-term implications for how humans reproduce rank among the most profound questions biotech will ever force us to answer. The pattern I warn about everywhere: the science sprints ahead of the ethics. Start thinking now, before the first company sells it as a lifestyle choice.

The market built for older adults: $4.5 trillion today, growing 7% a year, past $9 trillion by 2036 on my call. The base is the over-60s' $19 trillion of spending. The growth is in prevention, biomarkers, personalized diagnostics, age-tech and the services that keep people out of hospital and living at home.

By 2030 genomics and biotech become as important to farming as machinery. This is one of the biggest AgTech shifts people underestimate. Traditional crop breeding can take years. Genomics, gene editing and AI-assisted breeding can speed up the search for crops that tolerate drought, resist disease, use fewer inputs and produce better yields. Biotech also reaches beyond crops. It includes biological fertilizers, biological pest control, alternative proteins, lab-grown food and microorganisms designed to improve soil and plant health. This is where agriculture starts merging with biology, software and data science. My forecast: by 2030 genomics and biotech become as important to agriculture as machinery. The next agricultural revolution will not only happen in the field. Part of it will happen in the lab.

Every day. A police or fire drone reaches the scene in 90 seconds; a patrol car takes 7 minutes. Zipline flies blood and medicine to villages with no road. Firefighters see hotspots through smoke with thermal cameras. It is the smallest slice of my $150 billion drone market in 2030, $3 billion, and the one I care about most.

They fit human environments. A humanoid walks, grasps and adapts inside factories, hospitals and homes built for people, no redesign needed. The tailwind is a labor crisis nobody can vote away: 85 million unfilled jobs by 2030 and $8.5 trillion in unrealized annual revenue while populations age.

Because the generals already did the math. NATO's new target is 5% of GDP. The Pentagon's 2027 request is $1.5 trillion, the largest in history. And AI turns rearmament exponential: the same curve that builds humanoids and cures disease builds the most capable weapons in history.

Digital twins are live virtual copies of people, machines, factories, and cities, fed by real-time data. I predict they become essential across healthcare, manufacturing, cities, and infrastructure, letting organizations simulate outcomes, boost efficiency, and cut risk. Siemens runs digital twins of entire plants, Nvidia builds them for warehouses and cities, and Singapore has a twin of the whole island. You test the change on the twin before you touch the real thing. It turns expensive, dangerous experiments into cheap, safe simulations. Mistakes get made in software, not in reality. By 2030 no serious factory, hospital, or city runs without one.

The same disease as the EU: bureaucracy and bad timing. The speed and timing of innovation is vital to competitiveness. Blockbuster ignored it. Kodak ignored it. Now the German car manufacturers. Advertising wins quarters, innovation wins decades. Germany bought quarters. China bought the decade.